Experts Answer Questions on Current and Emerging Options for Hemophilia A Management

Decera Clinical Education Oncology Podcast · Jan 14, 2022 · 12m

In this podcast episode, 3 experts answers questions on the management of hemophilia A from a live webinar. Topics include:

Which patients should have pharmacokinetic-guided therapy?

Toxicities with PEGylated extended half-life products

Factor VIII and bone health

Factor VIII peaks, thrombotic risk, and cardiovascular disease

Choosing between extended half-life products and emicizumab for active patients

Role of fitusiran in the treatment paradigm if approved

Presenters:

Miguel A. Escobar, MD

Professor of Medicine and Pediatrics

Department of Hematology

University of Texas Health Science…